CIAM
PSTX

Caitong International Asset Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Caitong International Asset Management’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-75
Closed -$720 – 2613
2024
Q4 		$720 Buy
+75
New +$391 ﹤0.01% 1394

Other funds holding PSTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caitong International Asset Management's PSTX Position: Q1 2025 in Review

Caitong International Asset Management sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 75 shares — an estimated $720 sold.

Caitong International Asset Management first reported a position in PSTX in Q4 2024 and held it in 1 quarter. The position peaked at $720 in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

  • Caitong International Asset Management reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Caitong International Asset Management sold 75 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $720.
  • Caitong International Asset Management first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
  • Caitong International Asset Management's Poseida Therapeutics, Inc. Common Stock position peaked at $720 in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Caitong International Asset Management's 13F filing for Q1 2025, filed 13 May 2025.